What are the major opportunities in the Glioblastoma Multiforme (GBM) Treatment market? What are the strategies for the Glioblastoma Multiforme (GBM) Treatment market?

For detailed insights on the major opportunities and strategies in the Glioblastoma Multiforme (GBM) Treatment market, Read More

How does the Glioblastoma Multiforme (GBM) Treatment market relate to the overall economy and other similar markets?

For detailed insights on Glioblastoma Multiforme (GBM) Treatment's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Glioblastoma Multiforme (GBM) Treatment market growth? SWOT analysis of the Glioblastoma Multiforme (GBM) Treatment market.

For detailed insights on the key dynamics influencing the Glioblastoma Multiforme (GBM) Treatment market growth and SWOT analysis of the Glioblastoma Multiforme (GBM) Treatment industry, Read More

Glioblastoma Multiforme (GBM) Treatment Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Glioblastoma Multiforme (GBM) Treatment Market Report 2026

Name: Glioblastoma Multiforme (GBM) Treatment Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Treatment (Surgery, Radiation Therapy, Chemotherapy, R Immunotherapy), By Drug Class (Temozolomide, Bevacizumab, Lomustine, Carmustine Wafers, Other Drug Classes), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By End-Use (Hospitals, Clinics, Ambulatory Surgical Centers) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Glioblastoma Multiforme (GBM) Treatment Market Overview

• Glioblastoma Multiforme (GBM) Treatment market size has reached to $2.73 billion in 2025

• Expected to grow to $4.46 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%

• Growth Driver: Rising Cases Of Brain Disorder

• Market Trend: Innovative Devices Enhancing Glioblastoma Multiforme Treatment Landscape

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Glioblastoma Multiforme (GBM) Treatment Market?

Glioblastoma multiforme (GBM) treatment refers to the management and care of a patient suffering from glioblastoma multiforme, a kind of brain or spinal cord tumor that grows quickly. Adults with this primary malignant brain tumor have the highest prevalence rate.

The main treatment of glioblastoma multiforme (GBM) treatment are surgery, radiation therapy, chemotherapy, targeted therapy, tumor treating field (TTF) therapy, and immunotherapy. Surgery is a field of medicine that focuses on using manual and instrumental methods to heal wounds, illnesses, and other ailments. The drugs types involved are emozolomide, bevacizumab, lomustine, carmustine wafers, and others that are administered by oral, parenteral, other routes of administration and used by hospitals, clinics, ambulatory surgical centers.

Glioblastoma Multiforme (GBM) Treatment Market Global Report 2026 Market Report bar graph

What Is The Glioblastoma Multiforme (GBM) Treatment Market Size and Share 2026?

The glioblastoma multiforme (gbm) treatment market size has grown rapidly in recent years. It will grow from $2.73 billion in 2025 to $3.02 billion in 2026 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to limited survival outcomes, reliance on surgery and radiation, chemotherapy standardization, growth of neuro-oncology centers, increased brain tumor diagnosis.

What Is The Glioblastoma Multiforme (GBM) Treatment Market Growth Forecast?

The glioblastoma multiforme (gbm) treatment market size is expected to see rapid growth in the next few years. It will grow to $4.46 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to development of targeted therapies, expansion of immunotherapy pipelines, precision medicine adoption, increased clinical trial activity, rising research funding. Major trends in the forecast period include rising adoption of multimodal treatment regimens, increased use of tumor treating field therapy, growing focus on personalized gbm therapies, expansion of immunotherapy approaches, improved post-surgical treatment protocols.

Book your 30 minutes free consultation with our research experts

Global Glioblastoma Multiforme (GBM) Treatment Market Segmentation

1) By Treatment: Surgery, Radiation Therapy, Chemotherapy, R Immunotherapy

2) By Drug Class: Temozolomide, Bevacizumab, Lomustine, Carmustine Wafers, Other Drug Classes

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

4) By End-Use: Hospitals, Clinics, Ambulatory Surgical Centers

Subsegments:

1) By Surgery: Tumor Resection, Biopsy Procedures

2) By Radiation Therapy: External Beam Radiation Therapy (EBRT), Stereotactic Radiation Therapy

3) By Chemotherapy: Standard Chemotherapy, Combination Chemotherapy Regimens

4) By Immunotherapy: Checkpoint Inhibitors, Vaccine-Based Therapies

What Is The Driver Of The Glioblastoma Multiforme (GBM) Treatment Market?

The increasing prevalence of brain disorders is expected to propel the growth of the glioblastoma multiforme (GBM) treatment market going forward. Brain disorders refer to abnormal functioning of the brain as well as the nerves found throughout the human body and the spinal cord. The increasing prevalence of brain disorders such as glioblastoma multiforme (GBM) is due to various contributing factors such as the aging population, compromised immune systems, overdiagnosis, ionizing radiation, air pollution, and others which creates the need for the treatment of brain disorders to improve well-being. For instance, in February 2025, according to Dementia Australia, an Australia-based non-profit organization, approximately 433,300 Australians are living with dementia, with this number expected to rise to 812,500 by 2054. Additionally, younger-onset dementia affects around 29,000 people in 2025, with projections indicating an increase to 41,000 by 2054. Therefore, the increasing prevalence of brain disorders is driving the growth of the glioblastoma multiforme (GBM) treatment industry.

Key Players In The Global Glioblastoma Multiforme (GBM) Treatment Market

Major companies operating in the glioblastoma multiforme (gbm) treatment market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca PLC, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Jazz Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Varian Medical Systems Inc., Amneal Pharmaceuticals Inc., Elekta AB, Loxo Oncology Inc., Karyopharm Therapeutics Inc., EnGeneIC Ltd., Genenta Science S.r.l., Cantex Pharmaceuticals Inc., Vascular Biogenics Ltd., Seelos Therapeutics Inc, Angiochem Inc., Diffusion Pharmaceuticals Inc

Global Glioblastoma Multiforme (GBM) Treatment Market Trends and Insights

Major companies operating in the market are focused on development of innovative wearable and portable devices to sustain their position in the market. These advancements aim to offer users enhanced functionality, convenience, and comfort, catering to the growing demand for accessible and efficient healthcare solutions. For instance, in 2023, Novocure, a Jersey-based oncology company, launched Optune Gio, a wearable and portable treatment system for patients with newly diagnosed glioblastoma (GBM), approved by the FDA. This device employs Tumor Treating Fields (TTFields), which are alternating electric fields that disrupt cancer cell division, potentially extending patient survival. Weighing only 2.7 pounds, Optune Gio is designed for comfort, allowing patients to wear it during daily activities.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Glioblastoma Multiforme (GBM) Treatment Market?

In October 2024, Merck & Co., a US-based pharmaceutical company specializing in prescription medicines and vaccines, acquired Modifi Biosciences for an undisclosed amount. Through this acquisition, Merck aims to advance its oncology pipeline by integrating Modifi’s preclinical small-molecule platform, which targets cancer cells with defects in deoxyribonucleic acid (DNA) repair, including those lacking the O6-methylguanine-DNA methyltransferase (MGMT) protein, and shows potential against highly refractory tumors such as glioblastoma. Modifi Biosciences Inc. is a US-based company that provides a treatment targeting Glioblastoma Multiforme (GBM).

Regional Outlook

North America was the largest region in the glioblastoma multiforme (GBM) treatment market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Glioblastoma Multiforme (GBM) Treatment Market?

The glioblastoma multiforme (GBM) treatment market includes revenues earned by entities by performing neurological exams, imaging tests, surgical operations, radiotherapy, and molecular profiling. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Glioblastoma Multiforme (GBM) Treatment Market Report 2026?

The glioblastoma multiforme (gbm) treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the glioblastoma multiforme (gbm) treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Glioblastoma Multiforme (GBM) Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$3.02 billion
Revenue Forecast In 2035	$4.46 billion
Growth Rate	CAGR of 10.7% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Treatment, Drug Class, Route Of Administration, End-Use
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca PLC, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Jazz Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Varian Medical Systems Inc., Amneal Pharmaceuticals Inc., Elekta AB, Loxo Oncology Inc., Karyopharm Therapeutics Inc., EnGeneIC Ltd., Genenta Science S.r.l., Cantex Pharmaceuticals Inc., Vascular Biogenics Ltd., Seelos Therapeutics Inc, Angiochem Inc., Diffusion Pharmaceuticals Inc
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Glioblastoma Multiforme (GBM) Treatment Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Glioblastoma Multiforme (GBM) Treatment Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Glioblastoma Multiforme (GBM) Treatment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Glioblastoma Multiforme (GBM) Treatment Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics And Precision Medicine

4.1.2 Artificial Intelligence And Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data And Cybersecurity

4.1.4 Industry 4.0 And Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech And Circular Economy

4.2. Major Trends

4.2.1 Rising Adoption Of Multimodal Treatment Regimens

4.2.2 Increased Use Of Tumor Treating Field Therapy

4.2.3 Growing Focus On Personalized Gbm Therapies

4.2.4 Expansion Of Immunotherapy Approaches

4.2.5 Improved Post-Surgical Treatment Protocols

5. Glioblastoma Multiforme (GBM) Treatment Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Oncology Clinics

5.3 Neurosurgery Centers

5.4 Ambulatory Surgical Centers

5.5 Cancer Research Institutes

6. Glioblastoma Multiforme (GBM) Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Glioblastoma Multiforme (GBM) Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Glioblastoma Multiforme (GBM) Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Glioblastoma Multiforme (GBM) Treatment Market Size, Comparisons And Growth Rate Analysis

7.3. Global Glioblastoma Multiforme (GBM) Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Glioblastoma Multiforme (GBM) Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Glioblastoma Multiforme (GBM) Treatment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Glioblastoma Multiforme (GBM) Treatment Market Segmentation

9.1. Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Surgery, Radiation Therapy, Chemotherapy, Immunotherapy

9.2. Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Temozolomide, Bevacizumab, Lomustine, Carmustine Wafers, Other Drug Classes

9.3. Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral, Other Route Of Administrations

9.4. Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Ambulatory Surgical Centers

9.5. Global Glioblastoma Multiforme (GBM) Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tumor Resection, Biopsy Procedures

9.6. Global Glioblastoma Multiforme (GBM) Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

External Beam Radiation Therapy (EBRT), Stereotactic Radiation Therapy

9.7. Global Glioblastoma Multiforme (GBM) Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Standard Chemotherapy, Combination Chemotherapy Regimens

9.8. Global Glioblastoma Multiforme (GBM) Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Checkpoint Inhibitors, Vaccine-Based Therapies

10. Glioblastoma Multiforme (GBM) Treatment Market Regional And Country Analysis

10.1. Global Glioblastoma Multiforme (GBM) Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Glioblastoma Multiforme (GBM) Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Glioblastoma Multiforme (GBM) Treatment Market

11.1. Asia-Pacific Glioblastoma Multiforme (GBM) Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Glioblastoma Multiforme (GBM) Treatment Market

12.1. China Glioblastoma Multiforme (GBM) Treatment Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Glioblastoma Multiforme (GBM) Treatment Market

13.1. India Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Glioblastoma Multiforme (GBM) Treatment Market

14.1. Japan Glioblastoma Multiforme (GBM) Treatment Market Overview

14.2. Japan Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Glioblastoma Multiforme (GBM) Treatment Market

15.1. Australia Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Glioblastoma Multiforme (GBM) Treatment Market

16.1. Indonesia Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Glioblastoma Multiforme (GBM) Treatment Market

17.1. South Korea Glioblastoma Multiforme (GBM) Treatment Market Overview

17.2. South Korea Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Glioblastoma Multiforme (GBM) Treatment Market

18.1. Taiwan Glioblastoma Multiforme (GBM) Treatment Market Overview

18.2. Taiwan Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Glioblastoma Multiforme (GBM) Treatment Market

19.1. South East Asia Glioblastoma Multiforme (GBM) Treatment Market Overview

19.2. South East Asia Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Glioblastoma Multiforme (GBM) Treatment Market

20.1. Western Europe Glioblastoma Multiforme (GBM) Treatment Market Overview

20.2. Western Europe Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Glioblastoma Multiforme (GBM) Treatment Market

21.1. UK Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Glioblastoma Multiforme (GBM) Treatment Market

22.1. Germany Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Glioblastoma Multiforme (GBM) Treatment Market

23.1. France Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Glioblastoma Multiforme (GBM) Treatment Market

24.1. Italy Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Glioblastoma Multiforme (GBM) Treatment Market

25.1. Spain Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Glioblastoma Multiforme (GBM) Treatment Market

26.1. Eastern Europe Glioblastoma Multiforme (GBM) Treatment Market Overview

26.2. Eastern Europe Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Glioblastoma Multiforme (GBM) Treatment Market

27.1. Russia Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Glioblastoma Multiforme (GBM) Treatment Market

28.1. North America Glioblastoma Multiforme (GBM) Treatment Market Overview

28.2. North America Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Glioblastoma Multiforme (GBM) Treatment Market

29.1. USA Glioblastoma Multiforme (GBM) Treatment Market Overview

29.2. USA Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Glioblastoma Multiforme (GBM) Treatment Market

30.1. Canada Glioblastoma Multiforme (GBM) Treatment Market Overview

30.2. Canada Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Glioblastoma Multiforme (GBM) Treatment Market

31.1. South America Glioblastoma Multiforme (GBM) Treatment Market Overview

31.2. South America Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Glioblastoma Multiforme (GBM) Treatment Market

32.1. Brazil Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Glioblastoma Multiforme (GBM) Treatment Market

33.1. Middle East Glioblastoma Multiforme (GBM) Treatment Market Overview

33.2. Middle East Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Glioblastoma Multiforme (GBM) Treatment Market

34.1. Africa Glioblastoma Multiforme (GBM) Treatment Market Overview

34.2. Africa Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Glioblastoma Multiforme (GBM) Treatment Market Regulatory and Investment Landscape

36. Glioblastoma Multiforme (GBM) Treatment Market Competitive Landscape And Company Profiles

36.1. Glioblastoma Multiforme (GBM) Treatment Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Glioblastoma Multiforme (GBM) Treatment Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Glioblastoma Multiforme (GBM) Treatment Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Glioblastoma Multiforme (GBM) Treatment Market Other Major And Innovative Companies

AstraZeneca PLC, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Jazz Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Varian Medical Systems Inc., Amneal Pharmaceuticals Inc., Elekta AB, Loxo Oncology Inc., Karyopharm Therapeutics Inc., EnGeneIC Ltd., Genenta Science S.r.l., Cantex Pharmaceuticals Inc., Vascular Biogenics Ltd.

38. Global Glioblastoma Multiforme (GBM) Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Glioblastoma Multiforme (GBM) Treatment Market

40. Glioblastoma Multiforme (GBM) Treatment Market High Potential Countries, Segments and Strategies

40.1 Glioblastoma Multiforme (GBM) Treatment Market In 2030 - Countries Offering Most New Opportunities

40.2 Glioblastoma Multiforme (GBM) Treatment Market In 2030 - Segments Offering Most New Opportunities

40.3 Glioblastoma Multiforme (GBM) Treatment Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Glioblastoma Multiforme (GBM) Treatment Market, Overview Of Key Products - Product Examples

Table 2: Global Glioblastoma Multiforme (GBM) Treatment Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Glioblastoma Multiforme (GBM) Treatment Market, Supply Chain Analysis

Table 4: Global Glioblastoma Multiforme (GBM) Treatment Market, Major Raw Material Providers

Table 5: Global Glioblastoma Multiforme (GBM) Treatment Market, Major Resource Providers

Table 6: Global Glioblastoma Multiforme (GBM) Treatment Market, Major Manufacturers (Suppliers)

Table 7: Global Glioblastoma Multiforme (GBM) Treatment Market, Major Distributors And Channel Partners

Table 8: Global Glioblastoma Multiforme (GBM) Treatment Market, Key Technologies & Future Trends

Table 9: Global Glioblastoma Multiforme (GBM) Treatment Market, Major Trends

Table 10: Global Glioblastoma Multiforme (GBM) Treatment Market, Major End Users

Table 11: Global Glioblastoma Multiforme (GBM) Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Glioblastoma Multiforme (GBM) Treatment Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Glioblastoma Multiforme (GBM) Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Glioblastoma Multiforme (GBM) Treatment Market - TAM, US$ Billion, 2025

Table 15: Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Glioblastoma Multiforme (GBM) Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Glioblastoma Multiforme (GBM) Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Glioblastoma Multiforme (GBM) Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Glioblastoma Multiforme (GBM) Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Glioblastoma Multiforme (GBM) Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Glioblastoma Multiforme (GBM) Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Glioblastoma Multiforme (GBM) Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Glioblastoma Multiforme (GBM) Treatment Market - Company Scoring Matrix

Table 99: Pfizer Inc. Financial Performance

Table 100: F. Hoffmann-La Roche AG Financial Performance

Table 101: Merck & Co. Inc. Financial Performance

Table 102: AbbVie Inc. Financial Performance

Table 103: Novartis AG Financial Performance

Table 104: Global Glioblastoma Multiforme (GBM) Treatment Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Glioblastoma Multiforme (GBM) Treatment Market, Competitive Dashboard

Table 106: Global Glioblastoma Multiforme (GBM) Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Glioblastoma Multiforme (GBM) Treatment Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Table 108: Global, Glioblastoma Multiforme (GBM) Treatment Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Table 109: Global, Glioblastoma Multiforme (GBM) Treatment Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Glioblastoma Multiforme (GBM) Treatment Market, Overview Of Key Products - Product Examples

Figure 2: Global Glioblastoma Multiforme (GBM) Treatment Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Glioblastoma Multiforme (GBM) Treatment Market, Supply Chain Analysis

Figure 4: Global Glioblastoma Multiforme (GBM) Treatment Market, Major Raw Material Providers

Figure 5: Global Glioblastoma Multiforme (GBM) Treatment Market, Major Resource Providers

Figure 6: Global Glioblastoma Multiforme (GBM) Treatment Market, Major Manufacturers (Suppliers)

Figure 7: Global Glioblastoma Multiforme (GBM) Treatment Market, Major Distributors And Channel Partners

Figure 8: Global Glioblastoma Multiforme (GBM) Treatment Market, Key Technologies & Future Trends

Figure 9: Global Glioblastoma Multiforme (GBM) Treatment Market, Major Trends

Figure 10: Global Glioblastoma Multiforme (GBM) Treatment Market, Major End Users

Figure 11: Global Glioblastoma Multiforme (GBM) Treatment Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Glioblastoma Multiforme (GBM) Treatment Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Glioblastoma Multiforme (GBM) Treatment Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Glioblastoma Multiforme (GBM) Treatment Market - TAM, US$ Billion, 2025

Figure 15: Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Glioblastoma Multiforme (GBM) Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Glioblastoma Multiforme (GBM) Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Glioblastoma Multiforme (GBM) Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Glioblastoma Multiforme (GBM) Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Glioblastoma Multiforme (GBM) Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Glioblastoma Multiforme (GBM) Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Glioblastoma Multiforme (GBM) Treatment Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Glioblastoma Multiforme (GBM) Treatment Market - Company Scoring Matrix

Figure 99: Pfizer Inc. Financial Performance

Figure 100: F. Hoffmann-La Roche AG Financial Performance

Figure 101: Merck & Co. Inc. Financial Performance

Figure 102: AbbVie Inc. Financial Performance

Figure 103: Novartis AG Financial Performance

Figure 104: Global Glioblastoma Multiforme (GBM) Treatment Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Glioblastoma Multiforme (GBM) Treatment Market, Competitive Dashboard

Figure 106: Global Glioblastoma Multiforme (GBM) Treatment Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Glioblastoma Multiforme (GBM) Treatment Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Figure 108: Global, Glioblastoma Multiforme (GBM) Treatment Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Figure 109: Global, Glioblastoma Multiforme (GBM) Treatment Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Global Outpatient Clinics Market Forecast to Reach $53.81 Billion by 2029, Driven by 5.3% CAGR

Outpatient Home Therapy Industry Poised for Rapid Expansion, Projected to Hit $72.97 Billion by 2029

In-Depth Outpatient Oncology Infusion Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Outpatient Rehabilitation Services Market

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

OBGYN EMR Software Market Report 2026 - Global Outlook – By Product Type (On-Premise, Cloud-Based), By Deployment (Web-Based, Mobile-Based), By Application (Hospitals, Clinics), By End-User (Physicians, Patients) - Marke...

AR And VR Smart Glasses Market Report 2026 - Global Outlook – By Display Technology ( Optical See Through, Video See Through), By Device Type ( Binocular, Monocular), By Product ( Mobile Phone Smart Glasses, Integrated S...

Game Engine Market Report 2026 - Global Outlook – By Type (3D Game Engines, 2.5D Game Engines, 2D Game Engines, Other Types), By Component (Solution, Services), By Platform (Mobile, Console, Computer, Other Platforms), B...

Ectopic Pregnancy Market Report 2026 - Global Outlook – By Type (Tubal Ectopic Pregnancy, Non-Tubal Ectopic Pregnancy, Heterotopic Ectopic Pregnancy, Other Types), By Treatment (Folic Acid Analogue, Corticosteroid, Other...

Brain Tumor Drugs Market Report 2026 - Global Outlook – By Drugs (Temozolomide, Bevacizumab, Other Drugs), By End User (Hospital Pharmacies, Retail Pharmacies Or Drug Stores, Other End-Users), By Mechanism of Action (Che...

Automotive Overhead Console Market Report 2026 - Global Outlook – By Console Type (Front End Console, Rear End Console), By Technology (Electro-Mechanical, Capacitive, Display), By Vehicle Type (Passenger Vehicle, Light ...

Relationship Genetic Tests Market Report 2026 - Global Outlook – By Type (Siblings DNA Test, Grandparentage Test, Genetic Reconstruction Test, Other Types), By Sample (Saliva, Urine, Blood), By Application (Direct-To-Con...

Frequently Asked Questions

How big is the Glioblastoma Multiforme (GBM) Treatment Market?

The Glioblastoma Multiforme (GBM) Treatment market was valued at $2.73 billion in 2025, increased to $3.02 billion in 2026, and is projected to reach $4.46 billion by 2030.

What is the Glioblastoma Multiforme (GBM) Treatment market growth?

The global Glioblastoma Multiforme (GBM) Treatment market is expected to grow at a CAGR of 10.2% from 2026 to 2035 to reach $4.46 billion by 2035.

Who are the key players in Glioblastoma Multiforme (GBM) Treatment market?

Some Key Players in the Glioblastoma Multiforme (GBM) Treatment market Include, Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca PLC, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Indu

Major trend in this market includes: Innovative Devices Enhancing Glioblastoma Multiforme Treatment Landscape. For further insights on this market. request a sample here

North America was the largest region in the glioblastoma multiforme (GBM) treatment market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glioblastoma multiforme (g

Book your 30 minutes free consultation with our research experts

Contact Us